GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $2.30 $2.95 Monday, 22nd Apr 2024 CLLS stock ended at $2.64. This is 3.53% more than the trading day before Friday, 19th Apr 2024. During the day the stock fluctuated 2.32% from a day low at $2.59 to a day high of $2.65.
90 days $2.30 $3.13
52 weeks $0.96 $3.77

Historical Cellectis S.A. prices

Date Open High Low Close Volume
Jul 09, 2021 $15.14 $15.79 $14.90 $15.78 341 567
Jul 08, 2021 $13.95 $14.51 $13.55 $14.44 175 693
Jul 07, 2021 $14.89 $14.89 $14.14 $14.34 156 230
Jul 06, 2021 $15.23 $15.35 $14.68 $14.86 152 682
Jul 02, 2021 $16.01 $16.19 $15.05 $15.16 212 166
Jul 01, 2021 $15.45 $16.40 $15.36 $16.09 314 835
Jun 30, 2021 $15.61 $16.31 $15.22 $15.47 626 573
Jun 29, 2021 $16.06 $16.44 $15.80 $15.85 148 989
Jun 28, 2021 $16.21 $16.45 $15.79 $16.26 314 076
Jun 25, 2021 $15.42 $15.71 $15.23 $15.62 123 254
Jun 24, 2021 $14.83 $15.56 $14.82 $15.49 201 214
Jun 23, 2021 $14.47 $14.90 $14.47 $14.80 130 870
Jun 22, 2021 $14.42 $14.65 $14.20 $14.61 214 366
Jun 21, 2021 $14.80 $14.97 $14.44 $14.51 159 511
Jun 18, 2021 $14.85 $15.21 $14.81 $14.85 399 582
Jun 17, 2021 $14.50 $15.30 $14.50 $15.12 209 319
Jun 16, 2021 $15.27 $15.39 $14.40 $14.71 254 239
Jun 15, 2021 $16.08 $16.08 $14.97 $15.06 188 503
Jun 14, 2021 $15.55 $16.13 $15.48 $15.80 197 891
Jun 11, 2021 $15.41 $15.49 $15.05 $15.18 183 364
Jun 10, 2021 $15.00 $15.74 $14.91 $15.30 324 480
Jun 09, 2021 $14.98 $15.61 $14.90 $15.11 236 369
Jun 08, 2021 $15.38 $15.44 $14.46 $14.83 166 613
Jun 07, 2021 $14.67 $15.50 $14.34 $15.05 192 789
Jun 04, 2021 $14.53 $14.85 $14.30 $14.54 235 571
Click to get the best stock tips daily for free!

About Cellectis S.A.

Cellectis S.A. Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatment of CD19-expressing hematologic malignancies, such as acute lymphoblastic leukemia; ALLO-501 and ALL... CLLS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT